The team screened a highly selective kinase inhibitor library and found that CP-673451 can upregulate BTLA expression on immunocytes and reduce sepsis-related mortality (see image below).

ANB032 is a more high-risk/high-reward asset, given that historical studies with BTLA agonists were not positive. Ready to turn the market’s comeback into steady cash flow? Grab the top 3 stocks ...

The Nodexus SAB is chaired by Professor Jonni Moore, PhD, one of the world’s leading experts in flow cytometry, laboratory medicine, and cellular immunology. The SAB will provide strategic ...

Beckman Coulter Life Sciences, a provider of laboratory automation and innovation and an operating company of Danaher Corporation, has launched the CytoFLEX mosaic Spectral Detection Module, the ...

WEST LAFAYETTE, Ind. — A pioneer in the field reflects on the history and future of flow cytometry on its 50th anniversary in an article in the journal Science. J. Paul Robinson, The SVM Professor of ...